News

Researchers studying how cancer cells divide have revealed potential new viable therapeutic targets for cancer treatment.

A combined radiotherapy and immunotherapy treatment before surgery offers a less invasive treatment strategy for head and neck cancers that usually don't respond well to immunotherapy.

Scientists have pinpointed rogue immune cells as a major contributor to autoimmune conditions like rheumatoid arthritis and aplastic anaemia.

A novel method to treat brain cancer that doesn't involve heat, radiation or opening the skull has been developed by researchers at the University of Saskatchewan.

Researchers have discovered a potential drug target to treat renal cell carcinoma.

Researchers have designed cancer-fighting nanoparticles that deliver both a chemotherapy drug and a novel immunotherapy that can shrink colon and pancreatic tumors in mice.

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

According to a study, a single drug compound can help immune cells penetrate tumors, and cut off the tumor’s ability to burn testosterone as fuel in prostate cancer.

University of Galway researchers discover biomarkers that may help in determining tailored cancer treatment.

New structural insights into the tankyrase protein, which plays a key role in driving bowel cancer development, could pave the way towards better and less toxic cancer drugs.